Market Place
Sourcing Support
Lyell Immunopharma at Needham`s 25th Virtual Health Conference
07 Apr 2026 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Q4 2025 and Full-Year Business Update
12 Mar 2026 //
GLOBENEWSWIRE
Lyell Immunopharma Closes $50M Tranche, Names Smital Shah as CFO
09 Mar 2026 //
GLOBENEWSWIRE
Lyell Immunopharma Announces March Investor Participation Conf
23 Feb 2026 //
GLOBENEWSWIRE
Lyell Immunopharma Ronde-Cel Shows Durable CRs in B-Cell Lymphoma
07 Dec 2025 //
GLOBENEWSWIRE
Lyell Immunopharma Reveals Q3 2025 Business Highlights
12 Nov 2025 //
GLOBENEWSWIRE
Lyell Immunopharma Acquires Global Rights For CAR T-Cell Product
10 Nov 2025 //
GLOBENEWSWIRE
Lyell Present Ronde-Cel Data For Aggressive Large B-Cell Lymphoma
03 Nov 2025 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in Sept Investor Conference
02 Sep 2025 //
GLOBENEWSWIRE
Lyell Immunopharma Strengthens Capabilities with Key Appointments
09 Jun 2025 //
GLOBENEWSWIRE
Lyell Immunopharma at Goldman Sachs Global Healthcare Conference
04 Jun 2025 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Q1 2025 Business Highlights & Results
13 May 2025 //
GLOBENEWSWIRE
Lyell Immunopharma Presents New Data on LYL314 at ICML 2025
01 May 2025 //
GLOBENEWSWIRE
Lyell Immunopharma gets RMAT for LYL314 in Large B-Cell Lymphoma
15 Apr 2025 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Q4 and Full Year 2024 Results
11 Mar 2025 //
GLOBENEWSWIRE
Lyell Immunopharma Reports Business & Financial Results for Q3 2024
07 Nov 2024 //
GLOBENEWSWIRE
Lyell Presents Phase 1-2 Data for IMPT-314 in B-cell Lymphoma
05 Nov 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Completes Acquisition of ImmPACT Bio
31 Oct 2024 //
GLOBENEWSWIRE
Lyell Immunopharma To Acquire ImmPACT Bio For CAR T-cell
24 Oct 2024 //
GLOBENEWSWIRE
Lyell Announces Abstracts For SITC Annual Meeting
04 Oct 2024 //
GLOBENEWSWIRE
Lyell Immunopharma to Join Goldman Sachs Cell Therapy Day
24 Sep 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Announces Participation in September Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Lyell To Participate In Goldman Sachs Healthcare Conference
03 Jun 2024 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
06 May 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Announces Participation in March Investor Conferences
26 Feb 2024 //
GLOBENEWSWIRE
Lyell to Participate in 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation
27 Sep 2023 //
GLOBENEWSWIRE
Cellares & Lyell to Evaluate Manufacturing of Lyell`s CAR T-Cell Therapy
11 Sep 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in Upcoming Investor Conferences
31 Aug 2023 //
GLOBENEWSWIRE
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
05 Jul 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in Goldman Sachs Global Healthcare Conference
07 Jun 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
02 May 2023 //
GLOBENEWSWIRE
Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Conference
03 Jan 2023 //
GLOBENEWSWIRE
